Integra LifeSciences Holdings Corp.
IART
$0.00 (0.00%)
1D
1W
3M
1Y
5Y
ALL
Integra LifeSciences Holdings Corporation is a global medical technology company. The Company manufactures and sells medical technologies and products in two segments: Codman Specialty Surgical (CSS) and Tissue Technologies (TT). The CSS segment consists of technologies and instrumentation used for a range of specialties, such as neurosurgery, neurocritical care and otolaryngology. The CSS business consists of a portfolio of brands, such as Codman, DuraGen, DuraSeal, CUSA, Mayfield, Bactiseal, and Certas Plus, which are used for the management of multiple disease states, including brain tumors, traumatic brain injury, hydrocephalus and other neurological conditions. The Company provides instruments that are used in precision, specialty and general surgical procedures. The TT segment is focused on three main areas: complex wound surgery, surgical reconstruction and peripheral nerve repair. The TT segment offers skin and wound repair, bone grafts, and nerve and tendon repair products.
Open
Prior close
Today's high
Today's low
52 Week high
52 Week low
Seeking Alpha • 4 days ago • IART
Integra LifeSciences Holdings Corporation (IART) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
GlobeNewsWire • 6 days ago • IART
Integra LifeSciences Leadership to Present at the Citi 2025 Global Healthcare Conference
GlobeNewsWire • 12 days ago • IART
Integra LifeSciences Welcomes Policy Advancements Supporting Medicare Beneficiary Access
GlobeNewsWire • 26 days ago • IART
Integra LifeSciences Receives FDA 510(k) Clearance for Use of the CUSA® Clarity Ultrasonic Surgical Aspirator System for Cardiac Surgeries
Seeking Alpha • about a month ago • IART
Integra LifeSciences Holdings Corporation (IART) Q3 2025 Earnings Call Transcript
Charts and pricing are provided for informational purposes only. The current market data is delayed up to 15 minutes. The accuracy of any market data displayed is not guaranteed.